C4 Therapeutics Inc. (CCCC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for C4 Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
C4 Therapeutics Inc. (CCCC) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $395M. It trades at $3.40, up 5.76% today. Its overall quality score is 39 out of 100, ranked against the whole US market. 5 analysts' average target of $9.00 implies +164.7% from today's price. Kronos AI's 30-day forecast is +10.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $9.00 |
| Low – high | $7.00 – $11.00 |
| Analysts | 5 |
| Upside to average | +164.7% |
Kronos AI 30-day forecast
| Expected close | $3.55 (+10.5%) |
| Likely range | +3.4% … +21.6% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 12 |
| Solvency | 54 |
| Growth | 50 |
| Overall | 39 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator